Menotropins
- Generic Name
- Menotropins
- Brand Names
- Menopur
- Drug Type
- Biotech
- CAS Number
- 9002-68-0
- Unique Ingredient Identifier
- 8FYM5179QJ
- Background
Menotropins contains follicle stimulating hormone (FSH) and luteinizing hormone (LH) purified from the urine of postmenopausal women. It is used as a fertility medication that is injected either subcutaneously or intramuscularly. It is composed of LH with 2 subunits, alpha = 92 residues, beta = 121 residues and FSH with 2 subunits, alpha = 92 residues, beta=111 residues.
- Indication
For the treatment of female infertility
- Associated Therapies
- Assisted Reproductive Technology therapy
Corifollitropin Alpha and Ovarian Response
- Conditions
- Infertility, Female
- Interventions
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2020-06-04
- Lead Sponsor
- Hospital de Clinicas de Porto Alegre
- Target Recruit Count
- 300
- Registration Number
- NCT04416607
- Locations
- 🇧🇷
Centro de Reproduçao Humana Insemine, Porto Alegre, RGS, Brazil
🇧🇷Hospital de Clinicas de Porto Alegre, Porto Alegre, RGS, Brazil
FSH Followed by HMG vs FSH Plus HMG in IVF
- First Posted Date
- 2020-05-12
- Last Posted Date
- 2020-06-09
- Lead Sponsor
- Mansoura University
- Target Recruit Count
- 530
- Registration Number
- NCT04385342
- Locations
- 🇪🇬
Fertility Care Unit (FCU) in Mansoura University Hospital, Mansourah, Dakahlia, Egypt
🇪🇬Department of Obstetrics and Gynecology, Alexandria, Egypt
🇪🇬RAHEM Fertility Centre, Zagazig, Egypt
Different Protocols in Ovarian Stimulation in Intracytoplasmic Sperm Injection Cycles
- Conditions
- ART
- Interventions
- First Posted Date
- 2019-12-10
- Last Posted Date
- 2022-11-30
- Lead Sponsor
- Assiut University
- Registration Number
- NCT04193930
- Locations
- 🇪🇬
Women Health Hospital - Assiut university, Assiut, Egypt
Hormone Evaluation in Artificial Reproductive Technology
- Conditions
- Female Infertility
- Interventions
- First Posted Date
- 2018-11-09
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Lund University
- Target Recruit Count
- 810
- Registration Number
- NCT03737253
- Locations
- 🇸🇪
Reproductive Medicine Center, Malmö, Sweden
🇵🇱Poznan University of Medical Sciences, Poznań, Poland
HMG Stimulation Versus HRT for Endometrial Preparation Prior to Blastocyst Transfer in Moderate to Severe IUA Patients
- Conditions
- Infertility, FemaleIntrauterine Adhesion
- Interventions
- Drug: hormone replacement therapy
- First Posted Date
- 2018-07-06
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- Reproductive & Genetic Hospital of CITIC-Xiangya
- Target Recruit Count
- 186
- Registration Number
- NCT03578172
- Locations
- 🇨🇳
Reproductive & Genetic Hospital of CITIC-XIANGYA, Changsha, Hunan, China
Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders
- Conditions
- Infertility, Female
- Interventions
- First Posted Date
- 2017-06-06
- Last Posted Date
- 2019-09-12
- Lead Sponsor
- D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology
- Target Recruit Count
- 32
- Registration Number
- NCT03177538
- Locations
- 🇷🇺
D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology, Saint Petersburg, Russian Federation
Androgenic Profile Following Controlled Ovarian Stimulation
- First Posted Date
- 2016-12-14
- Last Posted Date
- 2016-12-20
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT02992808
A Study to Measure Relationship Between Antimüllerian Hormone and Initial Dose of Menopur®
- First Posted Date
- 2016-10-17
- Last Posted Date
- 2019-03-05
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 297
- Registration Number
- NCT02935335
- Locations
- 🇫🇷
Hospital FOCH (there may be other sites in this country), Suresnes, France
A Study on Efficacy and Safety of Menopur® Multidose in Korean Female Patients With Infertility
- First Posted Date
- 2016-07-18
- Last Posted Date
- 2019-03-28
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 412
- Registration Number
- NCT02835469
- Locations
- 🇰🇷
CL Hospital (there may be other sites in this country), Gwangju, Korea, Republic of
Letrozole and Sequential Clomiphene to Improve the Outcome of Embryo Transfer
- Conditions
- Female Infertility Due to Nonimplantation of Ovum
- Interventions
- First Posted Date
- 2016-05-18
- Last Posted Date
- 2017-06-23
- Lead Sponsor
- Navy General Hospital, Beijing
- Target Recruit Count
- 100
- Registration Number
- NCT02775877
- Locations
- 🇨🇳
Department of Obstetrics and Gynecology, Navy General Hospital., Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.